{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-089366","form_type":"8-K/A","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.099690+00:00","generated_at":"2026-06-11T21:17:17.936600+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ApolloMed Q2 revenue up 29% to $348.2M, net income +10%; guidance reaffirmed","bullets":["Total revenue $348.2M (+29% YoY); net income attributable to ApolloMed $13.2M (+10%); adjusted EBITDA $35.8M (+44%).","Care Partners revenue $325.2M (+32%); segment operating income surged 250% to $27.8M.","FY2023 guidance reaffirmed: total revenue $1.3B-$1.5B; adjusted EBITDA $120M-$160M; diluted EPS $0.95-$1.20.","Agreed to acquire Texas Independent Providers (120+ PCPs); partnered with IntraCare (425+ providers) with $25M convertible note.","Filing corrects balance sheet items: income taxes payable to $20.4M, total liabilities to $443.6M, mezzanine equity to $13.8M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-089366","json":"https://secwatch.observer/filing/0001104659-23-089366.json","markdown":"https://secwatch.observer/filing/0001104659-23-089366.md","text":"https://secwatch.observer/filing/0001104659-23-089366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/0001104659-23-089366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/tm2323203d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T21:17:17.936600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0bb5c12c4d6a7676fafea6a14e3ef693753f85e5","claim":"Astrana Health, Inc. reported six months ended June 30, 2023 results: revenue $685.5 million, net income $26.3 million. Guidance reaffirmed.","evidence_excerpt":"Financial Highlights for Six Months Ended June 30, 2023: All comparisons are to the six months ended June 30, 2022 unless otherwise stated. • Total revenue of $685.5 million, up 29% from $533.0 million • Care Partners revenue of $639.9 million, up 31% from $488.6 million • Net income attributable to ApolloMed of $26.3 million, up 2% from $25.7 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/0001104659-23-089366-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"six months ended June 30, 2023"},{"label":"Revenue","value":"$685.5 million"},{"label":"Net income","value":"$26.3 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"7d7005f3d7f78b20acac25d7af26a813a1c552d4","claim":"Astrana Health, Inc. reported second quarter ended June 30, 2023 results: revenue $348.2 million, net income $13.2 million. Guidance reaffirmed.","evidence_excerpt":"full-year 2023.” Financial Highlights for Second Quarter Ended June 30, 2023: All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Total revenue of $348.2 million, up 29% from $269.7 million • Care Partners revenue of $325.2 million, up 32% from $247.3 million • Net income attributable to ApolloMed of $13.2 million, up 10% from $12.0","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/0001104659-23-089366-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$348.2 million"},{"label":"Net income","value":"$13.2 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}